04.01.2020
Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™
- CDMO agreement for NanoFlu to support pathway to licensure
- Expanded collaboration now includes NanoFlu and COVID-19 vaccine...
Stay informed with news, insightful thought leadership, featured articles and engaging content from Emergent Bioservices and check out what events we’ll be attending throughout the year.
04.01.2020
03.23.2020
Original news coverage of Novavax's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine...
03.23.2020
Original news coverage of Vaxart's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine...
03.19.2020
GAITHERSBURG, Md.,March 18, 2020(GLOBE NEWSWIRE) --Emergent BioSolutions Inc.(NYSE:EBS) announced today that it has entered...
03.19.2020
GAITHERSBURG, Md.,March 10, 2020(GLOBE NEWSWIRE) --Emergent BioSolutions Inc.(NYSE:EBS) announced today that it has entered...